Plain-English translation of NCT05384392 on ClinicalTrials.gov ↗ · Source last updated · Translation generated ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
When someone has their first psychotic episode, doctors face a puzzle: there are different types of psychosis that look similar at first but need different treatments. This study is looking for biological markers — clues in your blood and patterns in your speech — that could help doctors figure out your specific type of psychosis much earlier. The researchers hope these markers will help predict how well you'll respond to treatment over the next two years.
Right now, doctors often can't tell which type of psychosis a patient has when they first get sick, which means treatment gets delayed and patients are at higher risk of relapse. By finding reliable early markers, this research could help doctors start the right treatment much faster and give patients better outcomes.
You likely qualify if…
You likely don't qualify if…
You'll complete a series of assessments including interviews about your symptoms, language recordings that will be analyzed for speech patterns, blood tests to check for biological markers, and brain imaging (MRI). The study will follow you for 2 years, checking in on how you're doing and how well your treatment is working. All of this helps researchers understand what early signs predict which type of psychosis you have and how you'll respond to treatment.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
France